<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PharmaLegacy | Preclinical CRO</title>
	<atom:link href="https://www.pharmalegacy.com/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.pharmalegacy.com/</link>
	<description></description>
	<lastBuildDate>Thu, 05 Nov 2026 07:03:57 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.5</generator>
	<item>
		<title>PHARMALEGACY TO EXHIBIT AT AASLD November 5-9 2026 IN Denver, CO</title>
		<link>https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-aasld-november-5-9-2026-in-denver-co/</link>
		
		<dc:creator><![CDATA[Michael Zhang]]></dc:creator>
		<pubDate>Thu, 05 Nov 2026 04:03:04 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<guid isPermaLink="false">https://www.pharmalegacy.com/?p=6827</guid>

					<description><![CDATA[<p>PharmaLegacy will be exhibiting at the 2026 meeting of the American Association for the Study of Liver Diseases (AASLD), November… <a href="https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-aasld-november-5-9-2026-in-denver-co/">Read More &#187;</a></p>
<p>The post <a href="https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-aasld-november-5-9-2026-in-denver-co/">PHARMALEGACY TO EXHIBIT AT AASLD November 5-9 2026 IN Denver, CO</a> appeared first on <a href="https://www.pharmalegacy.com">PharmaLegacy | Preclinical CRO</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p class="ds-markdown-paragraph"><span class="">PharmaLegacy will be exhibiting at the 2026 meeting of the American Association for the Study of Liver Diseases (AASLD), November 5-9 in Denver, CO. </span></p>
<p class="ds-markdown-paragraph"><span class="">Visit us at booth <strong>#1641</strong> and discuss predicting outcomes for potential treatments with our latest disease models.</span></p>
<p class="ds-markdown-paragraph"><span class="">We hope to see you in Denver!</span></p>
<p>&nbsp;</p>
<p><strong>↓ VIEW OUR POSTER HERE ↓ :</strong></p>
<h3><strong>《<a href="https://www.pharmalegacy.com/wp-content/uploads/2024/04/TLM2026_Poster_1435_V3.pdf">TLM2026_Poster_1435_V3</a>》</strong></h3>
<p>&nbsp;</p>
<p><img fetchpriority="high" decoding="async" class="alignnone size-full wp-image-6832" src="https://www.pharmalegacy.com/wp-content/uploads/2026/11/TLM2026_Poster_1435_V3_011-scaled.png" alt="" width="2560" height="1355" srcset="https://www.pharmalegacy.com/wp-content/uploads/2026/11/TLM2026_Poster_1435_V3_011-scaled.png 2560w, https://www.pharmalegacy.com/wp-content/uploads/2026/11/TLM2026_Poster_1435_V3_011-300x159.png 300w, https://www.pharmalegacy.com/wp-content/uploads/2026/11/TLM2026_Poster_1435_V3_011-1024x542.png 1024w, https://www.pharmalegacy.com/wp-content/uploads/2026/11/TLM2026_Poster_1435_V3_011-768x407.png 768w, https://www.pharmalegacy.com/wp-content/uploads/2026/11/TLM2026_Poster_1435_V3_011-1536x813.png 1536w, https://www.pharmalegacy.com/wp-content/uploads/2026/11/TLM2026_Poster_1435_V3_011-2048x1084.png 2048w" sizes="(max-width: 2560px) 100vw, 2560px" /></p>
<p>The post <a href="https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-aasld-november-5-9-2026-in-denver-co/">PHARMALEGACY TO EXHIBIT AT AASLD November 5-9 2026 IN Denver, CO</a> appeared first on <a href="https://www.pharmalegacy.com">PharmaLegacy | Preclinical CRO</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Catawba Research Announces Strategic Partnership With PharmaLegacy Laboratories</title>
		<link>https://www.pharmalegacy.com/catawba-research-announces-strategic-partnership-with-pharmalegacy-laboratories/</link>
		
		<dc:creator><![CDATA[Carlton Hoyt]]></dc:creator>
		<pubDate>Wed, 23 Oct 2024 19:15:25 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<guid isPermaLink="false">https://www.pharmalegacy.com/?p=5351</guid>

					<description><![CDATA[<p>Collaboration to Enhance Preclinical and Clinical Research Capabilities CHARLOTTE, N.C.; Oct. 22, 2024 (Business Wire) – Catawba Research, a leading… <a href="https://www.pharmalegacy.com/catawba-research-announces-strategic-partnership-with-pharmalegacy-laboratories/">Read More &#187;</a></p>
<p>The post <a href="https://www.pharmalegacy.com/catawba-research-announces-strategic-partnership-with-pharmalegacy-laboratories/">Catawba Research Announces Strategic Partnership With PharmaLegacy Laboratories</a> appeared first on <a href="https://www.pharmalegacy.com">PharmaLegacy | Preclinical CRO</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p style="text-align: center;"><i><span style="font-weight: 400;">Collaboration to Enhance Preclinical and Clinical Research Capabilities</span></i></p>
<p><b>CHARLOTTE, N.C.; Oct. 22, 2024 (Business Wire)</b><span style="font-weight: 400;"> – </span><a href="https://catawbaresearch.com/"><span style="font-weight: 400;">Catawba Research</span></a><span style="font-weight: 400;">, a leading global full-service Clinical Research Organization (CRO), is proud to announce a strategic partnership with </span><a href="https://www.pharmalegacy.com/"><span style="font-weight: 400;">PharmaLegacy Laboratories</span></a><span style="font-weight: 400;">, a recognized leader in preclinical contract research services. This collaboration is set to leverage both companies’ strengths, driving innovation and excellence in drug development and provides Catawba Research with new access to China, further expanding their APAC capabilities.</span></p>
<p><span style="font-weight: 400;">PharmaLegacy Laboratories specializes in advanced preclinical models and pharmacology research, with an emphasis on supporting biotechnology and pharmaceutical companies in their drug discovery and development efforts. The collaboration enhances Catawba Research’s outstanding agile solution offerings and scientific focus. </span></p>
<p><span style="font-weight: 400;">“We are thrilled to partner with PharmaLegacy,” said </span><a href="https://catawbaresearch.com/andrew-silverman-ph-d/"><span style="font-weight: 400;">Andy Silverman</span></a><span style="font-weight: 400;">, CEO of Catawba Research. “Their depth of expertise in preclinical research aligns perfectly with Catawba’s commitment to delivering high-quality, efficient clinical trial management. This collaboration allows us to offer end-to-end solutions for our clients, accelerating the drug development process while maintaining the highest standards of scientific integrity.”</span></p>
<p><a href="https://www.pharmalegacy.com/about-us/greeting-from-our-ceo/"><span style="font-weight: 400;">Jeff Duan</span></a><span style="font-weight: 400;">, CEO of PharmaLegacy, added, “Catawba Research has a stellar reputation in the clinical research space, and we believe that by combining our capabilities, we can offer our clients a truly comprehensive research experience. Together, we can help to bring new therapies to market to benefit patients more effectively and efficiently.”</span></p>
<p><span style="font-weight: 400;">The partnership will streamline drug development for our customers by offering a single source for both preclinical and clinical trial services. The combined expertise will ensure that drug candidates are tested and validated using the most rigorous methods, enabling faster and more reliable delivery of new treatments to patients in need.</span></p>
<p><b>About Catawba Research</b></p>
<p><a href="https://catawbaresearch.com/"><span style="font-weight: 400;">Catawba Research</span></a><span style="font-weight: 400;"> is a global full-service Clinical Research Organization that provides oversight, management, and implementation for Phase II and Phase III clinical trials. Headquartered in Charlotte, NC, Catawba works with drug-development sponsors to bring innovative treatments to the global market.</span></p>
<p><b>About PharmaLegacy Laboratories</b></p>
<p><a href="https://www.pharmalegacy.com/"><span style="font-weight: 400;">PharmaLegacy Laboratories</span></a><span style="font-weight: 400;">, headquartered in Shanghai, a global leading preclinical Contract Research Organization, is dedicated to accelerating the adoption of new therapies, resulting from the integration of new drug R&amp;D and translational research, by providing the most clinically relevant, science-based specialty pharmacology and toxicology services to global pharmaceutical and biotech companies enabling the development of new drugs and therapies.</span></p>
<p>The post <a href="https://www.pharmalegacy.com/catawba-research-announces-strategic-partnership-with-pharmalegacy-laboratories/">Catawba Research Announces Strategic Partnership With PharmaLegacy Laboratories</a> appeared first on <a href="https://www.pharmalegacy.com">PharmaLegacy | Preclinical CRO</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>PharmaLegacy acquires preclinical CRO BTS Research, strengthening its preclinical services and expanding laboratory operations into North America</title>
		<link>https://www.pharmalegacy.com/pharmalegacy-acquires-preclinical-cro-bts-research-strengthening-its-preclinical-services-and-expanding-laboratory-operations-into-north-america/</link>
		
		<dc:creator><![CDATA[Edgard Sayegh]]></dc:creator>
		<pubDate>Mon, 26 Aug 2024 06:21:41 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<guid isPermaLink="false">https://www.pharmalegacy.com/?p=5296</guid>

					<description><![CDATA[<p>PharmaLegacy Laboratories, a provider of in vitro and in vivo preclinical drug development services, has acquired BTS Research, a San… <a href="https://www.pharmalegacy.com/pharmalegacy-acquires-preclinical-cro-bts-research-strengthening-its-preclinical-services-and-expanding-laboratory-operations-into-north-america/">Read More &#187;</a></p>
<p>The post <a href="https://www.pharmalegacy.com/pharmalegacy-acquires-preclinical-cro-bts-research-strengthening-its-preclinical-services-and-expanding-laboratory-operations-into-north-america/">PharmaLegacy acquires preclinical CRO BTS Research, strengthening its preclinical services and expanding laboratory operations into North America</a> appeared first on <a href="https://www.pharmalegacy.com">PharmaLegacy | Preclinical CRO</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="p-pdf_iframe__page" aria-label="Page 1" data-page-number="1">
<div class="textLayer">
<p>PharmaLegacy Laboratories, a provider of <em>in vitro</em> and <em>in vivo</em> preclinical drug development services, has acquired BTS Research, a San Diego-based preclinical contract research organization (CRO).</p>
<p>As a reputable CRO providing preclinical pharmacology services to clients worldwide, PharmaLegacy’s acquisition of BTS Research is an important step in its continuing growth. San Diego is a significant global R&amp;D hub and the acquisition allows PharmaLegacy to join the greater community while also strengthening and expanding PharmaLegacy’s global research capabilities and service offerings.</p>
<p>“PharmaLegacy has been serving the US markets for many years, and a local presence in the San Diego biotechnology scene will accelerate our growth,” said Jeff Duan, founder &amp; CEO of PharmaLegacy. “This acquisition will allow us to better serve clients across the US and North America while increasing our study capacity and providing more flexibility for all of our clients. As such, it is a crucial step to becoming an industry-leading preclinical CRO.”</p>
<p>The synergy between PharmaLegacy and BTS Research creates a powerful combination that will further allow pharmaceutical, biotechnology, medical device, and diagnostics companies to obtain rapid and reliable pharmacology data to advance cures for patients. The combined companies possess decades of experience providing preclinical research services, and the acquisition of BTS will allow PharmaLegacy to add GLP toxicology services to our complete offering of pharmacology services.</p>
<p>“We are truly excited to be joining the PharmaLegacy family,” said Sami Abunadi, President of BTS Research. “As we further integrate our capabilities and knowledge, we will be able to deliver best-in-class research services to support drug, device, and diagnostic pipelines. This joining of forces will create a highly competitive global CRO.”</p>
<p>&nbsp;</p>
<h3>About PharmaLegacy Laboratories:</h3>
<p>PharmaLegacy is a CRO founded in 2008 which provides efficient and cost-effective preclinical in vitro and in vivo pharmacology studies to life science organizations. PharmaLegacy boasts over a thousand validated in vitro and in vivo services across over 40 different diseases, and has contributed to over 400 IND applications.</p>
<p>For more information on PharmaLegacy, visit <a href="https://www.pharmalegacy.com/">https://www.pharmalegacy.com/</a></p>
<p>&nbsp;</p>
<h3>About BTS Research:</h3>
<p>BTS Research is a San Diego-based Contract Research Organization that delivers GLP and Non-GLP biological services to clients in pharmaceutical, biopharmaceutical, biotech, academic research, medical device, and related industries, and has roots dating back to 2001 (formerly Bio-Quant, Inc. and BioTox Sciences). The Company was founded in 2007 and acquired Bio-Quant in 2011.</p>
<p>For more information on BTS Research, visit <a href="https://btsresearch.com/">https://btsresearch.com/</a></p>
<p>&nbsp;</p>
<p>Media contact:</p>
<p>Michael Zhang</p>
<p>Sr. Vice President of PharmaLegacy</p>
<p>michael.zhang@pharmalegacy.com</p>
</div>
</div>
<p>The post <a href="https://www.pharmalegacy.com/pharmalegacy-acquires-preclinical-cro-bts-research-strengthening-its-preclinical-services-and-expanding-laboratory-operations-into-north-america/">PharmaLegacy acquires preclinical CRO BTS Research, strengthening its preclinical services and expanding laboratory operations into North America</a> appeared first on <a href="https://www.pharmalegacy.com">PharmaLegacy | Preclinical CRO</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>PHARMALEGACY TO EXHIBIT AT BIO-EUROPE 2024 NOVEMBER 4-6 2024 IN STOCKHOLM SWEDEN</title>
		<link>https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-bio-europe-2024-november-4-6-2024-in-stockholm-sweden/</link>
		
		<dc:creator><![CDATA[Edgard Sayegh]]></dc:creator>
		<pubDate>Wed, 21 Aug 2024 13:17:18 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<guid isPermaLink="false">https://www.pharmalegacy.com/?p=5290</guid>

					<description><![CDATA[<p>PharmaLegacy will be exhibiting at the Bio-Europe November 4-6 in Stockholm. You can book a meeting with us here  to… <a href="https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-bio-europe-2024-november-4-6-2024-in-stockholm-sweden/">Read More &#187;</a></p>
<p>The post <a href="https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-bio-europe-2024-november-4-6-2024-in-stockholm-sweden/">PHARMALEGACY TO EXHIBIT AT BIO-EUROPE 2024 NOVEMBER 4-6 2024 IN STOCKHOLM SWEDEN</a> appeared first on <a href="https://www.pharmalegacy.com">PharmaLegacy | Preclinical CRO</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>PharmaLegacy will be exhibiting at the Bio-Europe November 4-6 in Stockholm. You can book a meeting with us <a href="https://partneringone.informaconnect.com/sign-in">here</a>  to discuss the how to bolster the global biotechnology industry, together.</p>
<p>You can <a href="https://informaconnect.com/bioeurope/booking-options/">register here</a> for Bio-Europe</p>
<p>We hope to see you in Stockholm!</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>The post <a href="https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-bio-europe-2024-november-4-6-2024-in-stockholm-sweden/">PHARMALEGACY TO EXHIBIT AT BIO-EUROPE 2024 NOVEMBER 4-6 2024 IN STOCKHOLM SWEDEN</a> appeared first on <a href="https://www.pharmalegacy.com">PharmaLegacy | Preclinical CRO</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>PHARMALEGACY TO EXHIBIT AT BIOTECH SUMMIT 2024 OCTOBER 10-11 2024 IN INNSBRUCK, AUSTRIA</title>
		<link>https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-biotech-summit-2024-october-10-11-2024-in-innsbruck-austria/</link>
		
		<dc:creator><![CDATA[Edgard Sayegh]]></dc:creator>
		<pubDate>Wed, 21 Aug 2024 06:25:16 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<guid isPermaLink="false">https://www.pharmalegacy.com/?p=5286</guid>

					<description><![CDATA[<p>PharmaLegacy will be exhibiting at the Biotech Summit October 10-11 in Innsbruck. You can book a meeting with us here … <a href="https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-biotech-summit-2024-october-10-11-2024-in-innsbruck-austria/">Read More &#187;</a></p>
<p>The post <a href="https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-biotech-summit-2024-october-10-11-2024-in-innsbruck-austria/">PHARMALEGACY TO EXHIBIT AT BIOTECH SUMMIT 2024 OCTOBER 10-11 2024 IN INNSBRUCK, AUSTRIA</a> appeared first on <a href="https://www.pharmalegacy.com">PharmaLegacy | Preclinical CRO</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>PharmaLegacy will be exhibiting at the Biotech Summit October 10-11 in Innsbruck. You can book a meeting with us <a href="https://partneringone.informaconnect.com/sign-in">here</a>  to discuss the latest trends and developments in biotechnology.</p>
<p>You can <a href="https://biotech-summit-austria.com/signup">register here</a> for Biotech Summit 2024</p>
<p>We hope to see you in Innsbruck!</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>The post <a href="https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-biotech-summit-2024-october-10-11-2024-in-innsbruck-austria/">PHARMALEGACY TO EXHIBIT AT BIOTECH SUMMIT 2024 OCTOBER 10-11 2024 IN INNSBRUCK, AUSTRIA</a> appeared first on <a href="https://www.pharmalegacy.com">PharmaLegacy | Preclinical CRO</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>PHARMALEGACY TO EXHIBIT AT NLS DAYS 2024 SEPTEMBER 18-19 2024 IN MALMÖ, SWEDEN</title>
		<link>https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-nls-days-2024-september-18-19-2024-in-malmo-sweden/</link>
		
		<dc:creator><![CDATA[Edgard Sayegh]]></dc:creator>
		<pubDate>Tue, 20 Aug 2024 21:04:36 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<guid isPermaLink="false">https://www.pharmalegacy.com/?p=5276</guid>

					<description><![CDATA[<p>PharmaLegacy will be exhibiting at the NLS Days &#8211; the largest Nordic partnering conference dedicated to the life science industry-… <a href="https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-nls-days-2024-september-18-19-2024-in-malmo-sweden/">Read More &#187;</a></p>
<p>The post <a href="https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-nls-days-2024-september-18-19-2024-in-malmo-sweden/">PHARMALEGACY TO EXHIBIT AT NLS DAYS 2024 SEPTEMBER 18-19 2024 IN MALMÖ, SWEDEN</a> appeared first on <a href="https://www.pharmalegacy.com">PharmaLegacy | Preclinical CRO</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>PharmaLegacy will be exhibiting at the NLS Days &#8211; the largest Nordic partnering conference dedicated to the life science industry- September 18-19 in Malmö. <a href="https://partneringone.informaconnect.com/sign-in">Book a meeting with us</a>  and let&#8217;s discuss the future of life sciences together.</p>
<p>You can <a href="https://www.nlsdays.com/registration-fees/">register here</a> for NLS Days 2024</p>
<p>We hope to see you in Malmö!</p>
<p>The post <a href="https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-nls-days-2024-september-18-19-2024-in-malmo-sweden/">PHARMALEGACY TO EXHIBIT AT NLS DAYS 2024 SEPTEMBER 18-19 2024 IN MALMÖ, SWEDEN</a> appeared first on <a href="https://www.pharmalegacy.com">PharmaLegacy | Preclinical CRO</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>PHARMALEGACY TO EXHIBIT AT ARVO MAY 5-9 2024 IN SEATTLE, WASHINGTON</title>
		<link>https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-arvo-may-5-9-in-seattle-washington/</link>
		
		<dc:creator><![CDATA[Edgard Sayegh]]></dc:creator>
		<pubDate>Wed, 17 Apr 2024 09:07:52 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<guid isPermaLink="false">https://www.pharmalegacy.com/?p=4691</guid>

					<description><![CDATA[<p>PharmaLegacy will be exhibiting at the 2024 meeting of the Association for Research in Vision &#38; Ophthalmology May 5–9 in… <a href="https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-arvo-may-5-9-in-seattle-washington/">Read More &#187;</a></p>
<p>The post <a href="https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-arvo-may-5-9-in-seattle-washington/">PHARMALEGACY TO EXHIBIT AT ARVO MAY 5-9 2024 IN SEATTLE, WASHINGTON</a> appeared first on <a href="https://www.pharmalegacy.com">PharmaLegacy | Preclinical CRO</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>PharmaLegacy will be exhibiting at the 2024 meeting of the Association for Research in Vision &amp; Ophthalmology May 5–9 in Seattle. Visit us at booth #4703 and discuss predicting outcomes for potential treatments with our latest ophthalmology models.</p>
<p>You can <a href="https://www.arvo.org/annual-meeting/registration2/registration/">register here</a> for ARVO 2024</p>
<p>We hope to see you in Seattle!</p>
<p>The post <a href="https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-arvo-may-5-9-in-seattle-washington/">PHARMALEGACY TO EXHIBIT AT ARVO MAY 5-9 2024 IN SEATTLE, WASHINGTON</a> appeared first on <a href="https://www.pharmalegacy.com">PharmaLegacy | Preclinical CRO</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>PHARMALEGACY ATTENDING BIO-EUROPE SPRING MARCH 18-20, 2024 IN SPAIN</title>
		<link>https://www.pharmalegacy.com/pharmalegacy-attending-bio-europe-spring-march-18-20-2024-in-spain/</link>
		
		<dc:creator><![CDATA[Edgard Sayegh]]></dc:creator>
		<pubDate>Mon, 11 Mar 2024 22:07:27 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<guid isPermaLink="false">https://pharmalegacy.com/?p=4597</guid>

					<description><![CDATA[<p>PharmaLegacy will be attending Bio-Europe Spring, March 18-20 in Barcelona Spain. Let&#8217;s connect there to discuss the latest trends and… <a href="https://www.pharmalegacy.com/pharmalegacy-attending-bio-europe-spring-march-18-20-2024-in-spain/">Read More &#187;</a></p>
<p>The post <a href="https://www.pharmalegacy.com/pharmalegacy-attending-bio-europe-spring-march-18-20-2024-in-spain/">PHARMALEGACY ATTENDING BIO-EUROPE SPRING MARCH 18-20, 2024 IN SPAIN</a> appeared first on <a href="https://www.pharmalegacy.com">PharmaLegacy | Preclinical CRO</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>PharmaLegacy will be attending Bio-Europe Spring, March 18-20 in Barcelona Spain. Let&#8217;s connect there to discuss the latest trends and challenges in the pharma industry.</p>
<p>You can <a href="https://informaconnect.com/bioeurope-spring/">register here for Bio-Europe Spring</a>, and email michael.zhang@pharmalegacy.com to schedule a meeting.</p>
<p>We hope to see you in Barcelona!</p>
<p>The post <a href="https://www.pharmalegacy.com/pharmalegacy-attending-bio-europe-spring-march-18-20-2024-in-spain/">PHARMALEGACY ATTENDING BIO-EUROPE SPRING MARCH 18-20, 2024 IN SPAIN</a> appeared first on <a href="https://www.pharmalegacy.com">PharmaLegacy | Preclinical CRO</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>PHARMALEGACY TO EXHIBIT AT AACR APRIL 7-10, 2024 IN CALIFORNIA</title>
		<link>https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-aacr-april-7-10-2024-in-california/</link>
		
		<dc:creator><![CDATA[Edgard Sayegh]]></dc:creator>
		<pubDate>Fri, 23 Feb 2024 17:54:31 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<guid isPermaLink="false">https://pharmalegacy.com/?p=4552</guid>

					<description><![CDATA[<p>PharmaLegacy will be exhibiting at the 2024 meeting of the American Association for Cancer Research April 7 – 10 in … <a href="https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-aacr-april-7-10-2024-in-california/">Read More &#187;</a></p>
<p>The post <a href="https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-aacr-april-7-10-2024-in-california/">PHARMALEGACY TO EXHIBIT AT AACR APRIL 7-10, 2024 IN CALIFORNIA</a> appeared first on <a href="https://www.pharmalegacy.com">PharmaLegacy | Preclinical CRO</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>PharmaLegacy will be exhibiting at the 2024 meeting of the American Association for Cancer Research April 7 – 10 in  California. Visit us at booth #4428 and let&#8217;s discuss how our latest <a href="https://pharmalegacy.com/indications/oncology-immuno-oncology/">oncology and immuno-oncology <em>in vitro</em> and <em>in vivo</em> models</a> can help you predict outcomes for potential treatments.</p>
<p>You can <a href="https://www.2024meeting.com/aacr/?gad_source=1&amp;gclid=Cj0KCQiAoeGuBhCBARIsAGfKY7wn4MQ3PaUip_OqbuDwkzpDkbF6JWZfgDq5chg_EOo0bruABqHB7KQaAr7TEALw_wcB">register here for AACR 2024</a></p>
<p>We hope to see you in California!</p>
<p>The post <a href="https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-aacr-april-7-10-2024-in-california/">PHARMALEGACY TO EXHIBIT AT AACR APRIL 7-10, 2024 IN CALIFORNIA</a> appeared first on <a href="https://www.pharmalegacy.com">PharmaLegacy | Preclinical CRO</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>PharmaLegacy to exhibit at ToxExpo March 11-13 2024 in Utah</title>
		<link>https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-toxexpo-march-11-13-2024-in-utah/</link>
		
		<dc:creator><![CDATA[Edgard Sayegh]]></dc:creator>
		<pubDate>Wed, 21 Feb 2024 11:40:32 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<guid isPermaLink="false">https://pharmalegacy.com/?p=4537</guid>

					<description><![CDATA[<p>PharmaLegacy will be exhibiting at the 2024  Society Of Toxicology&#8217;s 63rd annual meeting and ToxExpo March 11– 13 in Salt… <a href="https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-toxexpo-march-11-13-2024-in-utah/">Read More &#187;</a></p>
<p>The post <a href="https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-toxexpo-march-11-13-2024-in-utah/">PharmaLegacy to exhibit at ToxExpo March 11-13 2024 in Utah</a> appeared first on <a href="https://www.pharmalegacy.com">PharmaLegacy | Preclinical CRO</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>PharmaLegacy will be exhibiting at the 2024  Society Of Toxicology&#8217;s 63rd annual meeting and ToxExpo March 11– 13 in Salt Lake City. Visit us at booth #940 and let&#8217;s discuss how our fast, cost-effective <a href="https://pharmalegacy.com/services/toxicology/">toxicology services</a> can bolster your studies.</p>
<p>To register at ToxExpo 2024, visit <a href="https://www.toxicology.org/events/am/AM2024/registration.asp#:~:text=Exhibitor%20Registration,3115).">https://www.toxicology.org/events/am/AM2024/registration.asp#:~:text=Exhibitor%20Registration,3115).</a></p>
<p>We hope to see you in Salt Lake City!</p>
<p>The post <a href="https://www.pharmalegacy.com/pharmalegacy-to-exhibit-at-toxexpo-march-11-13-2024-in-utah/">PharmaLegacy to exhibit at ToxExpo March 11-13 2024 in Utah</a> appeared first on <a href="https://www.pharmalegacy.com">PharmaLegacy | Preclinical CRO</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>

<!--
Performance optimized by W3 Total Cache. Learn more: https://www.boldgrid.com/w3-total-cache/?utm_source=w3tc&utm_medium=footer_comment&utm_campaign=free_plugin

Page Caching using Disk: Enhanced 

Served from: www.pharmalegacy.com @ 2026-11-22 06:31:19 by W3 Total Cache
-->